AVEO PHARMACEUTICALS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Aveo Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2021.
  • Aveo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2022 was -$3.27M, a 68.5% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2022 was -$29M, a 49.6% increase year-over-year.
  • Aveo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$53.3M, a 49.9% decline from 2020.
  • Aveo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$35.6M, a 479% decline from 2019.
  • Aveo Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2019 was $9.39M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.